PD-1 inhibitors plus oxaliplatin or cisplatin-based chemotherapy in first-line treatments for advanced gastric cancer: A network meta-analysis

BACKGROUND: Currently, there has been no direct comparison between programmed cell death protein 1 (PD-1) inhibitors plus different chemotherapy regimens in first-line treatments for advanced gastric cancer (AGC). This study performed a network meta-analysis (NMA) to evaluate the efficacy and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Xiaoyu, Yang, Bowen, He, Lingzi, Sun, Yiting, Song, Yujia, Qu, Xiujuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393421/
https://www.ncbi.nlm.nih.gov/pubmed/36003374
http://dx.doi.org/10.3389/fimmu.2022.905651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393421/
https://www.ncbi.nlm.nih.gov/pubmed/36003374
http://dx.doi.org/10.3389/fimmu.2022.905651

Ejemplares similares